Wei Shi

6PUBLICATIONS
7CO-AUTHORS
BiomaterialsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 03, 2023
Nanobody-based bispecific T-cell engager (Nb-BiTE): a new platform for enhanced T-cell immunotherapy.

Xiao-Mei Yang, Xuan-Dong Lin, Wei Shi

|Sep 13, 2021
Endoglin-Aptamer-Functionalized Liposome-Equipped PD-1-Silenced T Cells Enhance Antitumoral Immunotherapeutic Effects.

Shenxia Xie, Xiaoqiong Hou, Wei Yang

|Nov 05, 2020
In vivo Targeting of Liver Cancer with Tissue- and Nuclei-Specific Mesoporous Silica Nanoparticle-Based Nanocarriers in mice.

Ziqiang Ding, Dujin Wang, Wei Shi

|Aug 24, 2016
The Lymphatic Immune Response Induced by the Adjuvant AS01: A Comparison of Intramuscular and Subcutaneous Immunization Routes.

Melanie R Neeland, Wei Shi, Catherine Collignon

Pageof 1